Prospective Registry of EoSinophilic esOphagitis

Launched by IRCCS SAN RAFFAELE · Jun 4, 2024

Keywords

ClinConnect Summary

This clinical trial, called the Prospective Registry of Eosinophilic Esophagitis, is focused on gathering information about patients diagnosed with Eosinophilic Esophagitis (EoE) at the San Raffaele Scientific Institute. EoE is a condition where a type of white blood cell, called eosinophils, build up in the esophagus, causing inflammation and difficulty swallowing. This study aims to create a comprehensive record of these patients to better understand the condition and improve treatment options.

To participate in this study, individuals must be diagnosed with EoE according to established guidelines and be willing to provide consent to take part. The trial is open to all genders and various age groups, although it has not begun recruiting participants yet. Those who join can expect to share their medical information, which will be used to help researchers learn more about EoE and its treatment. It’s important to note that individuals without a clear diagnosis of EoE or those who do not wish to consent will not be eligible for this registry.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Participant is willing and able to give informed consent for participation in the study.
• • 2. The medical product is the standard of care for the patient or the participant is taking the medicinal product according to clinical practice
• • 3. Being diagnosed with EoE as per guidelines of the disease
• Exclusion Criteria:
• • 1. No clear diagnosis of EoE
• • 2. Not willing to provide informed consent to the inclusion in the registry